Treatment of Coronary Artery Endothelial Cells with Serum Post-exercise Training Offers Limited Protection Against Exposure to FEC-T Chemotherapy
Overview
Authors
Affiliations
Chemotherapy treatment for breast cancer associates with well-documented cardiovascular detriments. Exercise has shown promise as a potentially protective intervention against cardiac toxicity. However, there is a paucity of evidence for the benefits of exercise on the vasculature. This study aimed to determine the effects of chemotherapy on the vascular endothelium; and if there are protective effects of serological alterations elicited by an exercise training intervention. 15 women participated in a 12-week home-based exercise intervention consisting of three high-intensity interval sessions per week. Human coronary artery endothelial cells (HCAEC) were exposed to physiological concentrations of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) and docetaxel to determine a dose-response. Twenty-4 hours prior to FEC and docetaxel exposure, HCAECs were preconditioned with serum collected pre- and post-training. Annexin V binding and cleaved caspase-3 were assessed using flow cytometry and wound repair by scratch assays. Chemotherapy exposure increased HCAEC Annexin V binding, cleaved caspase-3 expression in a dose-dependent manner; and inhibited wound repair. Compared to pre-training serum, conditioning HCAECs with post-training serum, reduced Annexin V binding (42% vs. 30%, = 0.01) when exposed to FEC. For docetaxel, there were no within-group differences (pre-vs post-exercise) for Annexin V binding or cleaved caspase-3 expression. There was a protective effect of post-training serum on wound repair for 5-flurouracil ( = 0.03) only. FEC-T chemotherapy drugs cause significant damage and dysfunction of endothelial cells. Preconditioning with serum collected after an exercise training intervention, elicited some protection against the usual toxicity of FEC-T, when compared to control serum.
Lin H, Chung M, Sun J, Yang Y, Zhang L, Pan X BMC Complement Med Ther. 2024; 24(1):158.
PMID: 38610025 PMC: 11010295. DOI: 10.1186/s12906-024-04445-x.
Ismaeel A, McDermott M, Joshi J, Sturgis J, Zhang D, Ho K Am J Physiol Cell Physiol. 2024; 326(2):C589-C605.
PMID: 38189132 PMC: 11193455. DOI: 10.1152/ajpcell.00573.2023.